SCHEMBL205059

SCHEMBL205059

O=[N+]([O-])c1cc(I)c(O)c(I)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 1.00
KMT2A Q03164 3/20 1.00
HTT P42858 2/20 1.00
LMNA P02545 1/20 1.00
SMN1; SMN2 Q16637 2/20 0.55
GALR3 O60755 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
GPR35 Q9HC97 5/20 0.53
ALDH1A1 P00352 3/20 0.53
TTR P02766 2/20 0.52
ALOX15 P16050 2/20 0.52
KDM4E B2RXH2 1/20 0.52
CYP1A2 P05177 1/20 0.52
MAPT P10636 1/20 0.52
CYP2C9 P11712 1/20 0.52
HPGD P15428 1/20 0.52
ALOX12 P18054 1/20 0.52
MAPK1 P28482 1/20 0.52
RECQL P46063 1/20 0.52
PMP22 Q01453 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12095462 0.98 MEN1 (0.95) MEN1KMT2AHTTLMNASMN1; SMN2
SCHEMBL12933087 0.92 MEN1 (0.84) MEN1KMT2AHTTLMNASMN1; SMN2
SCHEMBL28064550 0.86 MEN1 (0.74) MEN1KMT2AHTTLMNASMN1; SMN2
SCHEMBL482509 0.86 MEN1 (0.74) MEN1KMT2AHTTLMNASMN1; SMN2
SCHEMBL1530156 0.85 MEN1 (0.77) MEN1KMT2AHTTLMNASMN1; SMN2
SCHEMBL1530296 0.84 MEN1 (0.70) MEN1KMT2AHTTLMNASMN1; SMN2
SCHEMBL9550826 0.82 MEN1 (0.69) MEN1KMT2AHTTLMNASMN1; SMN2
SCHEMBL29173960 0.82 KMT2A (0.69) MEN1KMT2AHTTLMNASMN1; SMN2
SCHEMBL4871383 0.81 HTT (0.66) MEN1KMT2AHTTLMNASMN1; SMN2
SCHEMBL8528596 0.81 HTT (0.68) MEN1KMT2AHTTLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1249 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4586826-A1 FEED AND METHODS FOR CONTROLLING HEARTWORM INFECTIONS IN A MAMMAL In the Bowl Animal Health, Inc. (US) 2025-07-23 EP claimed
CN-114113370-B Analysis method of aromatic halogenated disinfection byproducts in water 东南大学 2024-03-26 CN claimed
WO-2024059837-A1 FEED AND METHODS FOR CONTROLLING HEARTWORM INFECTIONS IN A MAMMAL IN THE BOWL ANIMAL HEALTH, INC. (US) 2024-03-21 WO claimed
CN-114113370-A Analysis method of aromatic halogenated disinfection byproducts in water 东南大学 2022-03-01 CN claimed
EP-2115035-B1 POLYARYLENE SULFIDE RESIN WITH EXCELLENT LUMINOSITY AND PREPARATION METHOD THEREOF SK CHEMICALS CO LTD (KR) 2018-04-25 EP claimed
US-20170135347-A1 INSECTICIDAL, MITICIDAL, NEMATICIDAL, MOLLUSCICIDAL, MICROBICIDAL, OR BACTERICIDAL COMPOSITION AND METHOD FOR CONTROLLING PEST NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2017-05-18 US claimed
CN-106659160-A Insecticide, miticide, nematicide, molluscicide, disinfectant, or bactericide composition, and pest control method 日产化学工业株式会社 2017-05-10 CN claimed
EP-2097470-B1 METHOD FOR PRODUCTION OF POLYARYLENE SULFIDE RESIN WITH EXCELLENT LUMINOSITY AND THE POLYARYLENE SULFIDE RESIN SK CHEMICALS CO LTD (KR) 2017-03-22 EP claimed
US-8957182-B2 Polyarylene sulfide resin with excellent luminosity and preparation method thereof SK CHEMICALS CO., LTD. (KR) 2015-02-17 US claimed
US-8883960-B2 Polyarylene sulfide resin with excellent luminosity and preparation method thereof SK CHEMICALS CO., LTD. (KR) 2014-11-11 US claimed
EP-0694809-B1 A novel class of grain growth modifiers for the preparation of high chloride (111) tabular grain emulsions (II) EASTMAN KODAK CO (US) 1999-10-06 EP claimed
EP-0710105-A4 SYNERGISTIC ANTHELMINTIC COMPOSITIONS UNIV AUSTRALIAN (AU) 1998-06-10 EP claimed
EP-0710105-A1 SYNERGISTIC ANTHELMINTIC COMPOSITIONS THE AUSTRALIAN NATIONAL UNIVERSITY (AU) 1996-05-08 EP claimed
EP-0694809-A1 A novel class of grain growth modifiers for the preparation of high chloride (111) tabular grain emulsions (II) EASTMAN KODAK COMPANY (US) 1996-01-31 EP claimed
US-5411852-A A phenol with at least two iodo substituents EASTMAN KODAK COMPANY (US) 1995-05-02 US claimed
US-5411853-A A phenol with at least two iodo substituents EASTMAN KODAK COMPANY (US) 1995-05-02 US claimed
WO-1994028887-A1 SYNERGISTIC ANTHELMINTIC COMPOSITIONS THE AUSTRALIAN NATIONAL UNIVERSITY (AU) 1994-12-22 WO claimed
EP-0070198-B1 RADIATION-SENSITIVE COMPOSITION AND PATTERN-FORMATION METHOD USING THE SAME Hitachi, Ltd. (JP) 1985-06-19 EP claimed
EP-0070198-A1 Radiation-sensitive composition and pattern-formation method using the same Hitachi, Ltd. (JP) 1983-01-19 EP claimed
US-3957978-A ANTHELMINTICS AMERICAN CYANAMID COMPANY (US) 1976-05-18 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170135347-A1 INSECTICIDAL, MITICIDAL, NEMATICIDAL, MOLLUSCICIDAL, MICROBICIDAL, OR BACTERICIDAL COMPOSITION AND METHOD FOR CONTROLLING PEST DDT, ACHE, DRD5 MEN1 1767/4885KMT2A 239/4885HTT 3099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.